Healthcare provider profile · identity verified

Ravi Narra, MD

Internal Medicine · ELMORE, OH · NPI 1033197017

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	771	217
Amlodipine Besylate	Amlodipine Besylate	740	207
Losartan Potassium	Losartan Potassium	504	136
Levothyroxine Sodium	Levothyroxine Sodium	366	98
Metoprolol Succinate	Metoprolol Succinate	361	107
Metoprolol Tartrate	Metoprolol Tartrate	327	101
Omeprazole	Omeprazole	295	88
Lisinopril	Lisinopril	285	79
Eliquis	Apixaban	257	64
Furosemide	Furosemide	243	78
Rosuvastatin Calcium	Rosuvastatin Calcium	236	78
Gabapentin	Gabapentin	229	64
Allopurinol	Allopurinol	199	57
Meloxicam	Meloxicam	198	65
Januvia	Sitagliptin Phosphate	187	45
Glimepiride	Glimepiride	186	51
Metformin Hcl	Metformin Hcl	183	59
Pantoprazole Sodium	Pantoprazole Sodium	177	60
Hydrochlorothiazide	Hydrochlorothiazide	168	44
Carvedilol	Carvedilol	153	42
Isosorbide Mononitrate Er	Isosorbide Mononitrate	147	38
Escitalopram Oxalate	Escitalopram Oxalate	130	30
Potassium Chloride	Potassium Chloride	127	35
Clopidogrel	Clopidogrel Bisulfate	120	39
Tamsulosin Hcl	Tamsulosin Hcl	120	41
Celecoxib	Celecoxib	115	33
Albuterol Sulfate Hfa	Albuterol Sulfate	104	34
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	103	24
Sertraline Hcl	Sertraline Hcl	98	28
Citalopram Hbr	Citalopram Hydrobromide	97	28
Simvastatin	Simvastatin	94	29
Hydralazine Hcl	Hydralazine Hcl	93	22
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	86	24
Montelukast Sodium	Montelukast Sodium	71	19
Prednisone	Prednisone	70	26
Valsartan	Valsartan	70	19
Spironolactone	Spironolactone	66	22
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	64	18
Alfuzosin Hcl Er	Alfuzosin Hcl	63	17
Hydroxyzine Hcl	Hydroxyzine Hcl	61	14
Synthroid	Levothyroxine Sodium	61	19
Bisoprolol Fumarate	Bisoprolol Fumarate	60	13
Duloxetine Hcl	Duloxetine Hcl	58	16
Ozempic	Semaglutide	57	12
Lorazepam	Lorazepam	56	17
Atenolol	Atenolol	53	15
Fenofibrate	Fenofibrate Nanocrystallized	51	12
Fluticasone Propionate	Fluticasone Propionate	49	15
Famotidine	Famotidine	48	15
Finasteride	Finasteride	48	14
Methylprednisolone	Methylprednisolone	43	40
Metformin Hcl Er	Metformin Hcl	42	12
Warfarin Sodium	Warfarin Sodium	42	13
Donepezil Hcl	Donepezil Hcl	41	11
Ezetimibe	Ezetimibe	41	13
Meclizine Hcl	Meclizine Hcl	41	19
Paroxetine Hcl	Paroxetine Hcl	40	15
Doxycycline Hyclate	Doxycycline Hyclate	39	26
Ropinirole Hcl	Ropinirole Hcl	39	12
Jardiance	Empagliflozin	37	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	35	suppressed
Xarelto	Rivaroxaban	35	11
Bumetanide	Bumetanide	34	11
Oxybutynin Chloride Er	Oxybutynin Chloride	34	suppressed
Glipizide	Glipizide	33	suppressed
Diltiazem Hcl	Diltiazem Hcl	32	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	30	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	30	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	29	suppressed
Trulicity	Dulaglutide	28	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	27	26
Solifenacin Succinate	Solifenacin Succinate	27	11
Tramadol Hcl	Tramadol Hcl	27	suppressed
Nitroglycerin	Nitroglycerin	26	16
Alendronate Sodium	Alendronate Sodium	25	suppressed
Pravastatin Sodium	Pravastatin Sodium	25	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	24	suppressed
Diclofenac Sodium	Diclofenac Sodium	23	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	23	suppressed
Breo Ellipta	Fluticasone/Vilanterol	22	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	22	suppressed
Torsemide	Torsemide	22	suppressed
Verapamil Er	Verapamil Hcl	22	suppressed
Cefuroxime	Cefuroxime Axetil	21	20
Fluoxetine Hcl	Fluoxetine Hcl	21	suppressed
Trazodone Hcl	Trazodone Hcl	21	suppressed
Creon	Lipase/Protease/Amylase	20	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	20	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	20	suppressed
Buspirone Hcl	Buspirone Hcl	19	suppressed
Gemfibrozil	Gemfibrozil	19	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	19	suppressed
Levetiracetam	Levetiracetam	19	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	19	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	19	suppressed
Vascepa	Icosapent Ethyl	19	suppressed
Alprazolam	Alprazolam	18	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	18	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	17	suppressed
Entresto	Sacubitril/Valsartan	17	suppressed
Farxiga	Dapagliflozin Propanediol	17	suppressed
Memantine Hcl	Memantine Hcl	17	suppressed
Prazosin Hcl	Prazosin Hcl	17	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	16	suppressed
Betamethasone Dipropionate	Betamethasone Dipropionate	16	15
Clonidine Hcl	Clonidine Hcl	16	suppressed
Glipizide Er	Glipizide	16	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	16	suppressed
Amoxicillin	Amoxicillin	15	11
Cephalexin	Cephalexin	15	15
Droplet Pen Needle	Pen Needle, Diabetic	15	suppressed
Nystatin	Nystatin	15	11
Propranolol Hcl	Propranolol Hcl	15	suppressed
Tresiba Flextouch U-100	Insulin Degludec	15	suppressed
Azithromycin	Azithromycin	14	14
Cilostazol	Cilostazol	14	suppressed
Ibuprofen	Ibuprofen	14	suppressed
Ipratropium Bromide	Ipratropium Bromide	14	suppressed
Jantoven	Warfarin Sodium	14	suppressed
Primidone	Primidone	14	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	14	suppressed
Tradjenta	Linagliptin	14	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	13	suppressed
Fenofibrate	Fenofibrate	13	suppressed
Mirtazapine	Mirtazapine	13	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	13	suppressed
Scopolamine	Scopolamine	13	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	13	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	13	suppressed
Dutasteride	Dutasteride	12	suppressed
Klor-Con M20	Potassium Chloride	12	suppressed
Midodrine Hcl	Midodrine Hcl	12	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	12	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	12	12
Quetiapine Fumarate	Quetiapine Fumarate	12	suppressed
Repatha Sureclick	Evolocumab	12	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	12	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	12	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	11	suppressed
Bupropion Xl	Bupropion Hcl	11	suppressed
Glyburide-Metformin Hcl	Glyburide/Metformin Hcl	11	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	11	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	11	suppressed
Ondansetron Hcl	Ondansetron Hcl	11	suppressed
Ondansetron Odt	Ondansetron	11	suppressed
Ventolin Hfa	Albuterol Sulfate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error